CA
NZ
UK
AU
IND
US
HeartSciences Inc. filed Definitive Additional Materials on November 10, 2026, supplementing its October 19, 2026 proxy statement with updated information on the board composition and director biographies for the combined company expected to result from its pending merger with Fortitude Mining Holdings, Inc.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 2,026,991 shares of common stock in Perspective Therapeutics Inc as of September 30, 2026.
Nika Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing continued operating losses, no revenue, and a total stockholders' deficit of $343,705.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 17,459,736 shares of Prudential Financial Inc common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 5.1% of Progress Software Corp's common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 5,586,795 shares of Prosperity Bancshares Inc common stock as of September 30, 2026.
Stabilis Solutions, Inc. filed a Form 8-K on November 10, 2026, disclosing a three-year take-or-pay LNG supply agreement with an existing commercial aerospace customer for operations at the John C. Stennis Space Center in Hancock County, Mississippi.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 8,827,707 shares of Novavax Inc. common stock, representing 5.4 percent of the class, based on a triggering event dated September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 26,047,836 shares of News Corp common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of approximately 7.4% of Omnicom Group Inc.'s common stock as of September 30, 2026.
Please wait processing your request...